基于网络药理学探讨黄芪六君子汤治疗新冠肺炎恢复期的作用机制

doi:10.3976/j.issn.1002-4026.2020.05.002

摘要/Abstract

摘要： 基于网络药理学探讨黄芪六君子汤治疗新冠肺炎的作用机制。利用TCMSP、Pubchem、Swiss Target Prediction数据库挖掘黄芪六君子汤中的中药所含化学成分及作用靶点，并经Uniprot数据库标准化，通过GeneCards数据库获得新冠肺炎相关基因，将疾病与药物的靶点进行映射取交集，从STRING数据库下载蛋白-蛋白相互作用（PPI）数据，借助Cytoscape软件构建活性成分-靶点的可视化网络图、蛋白互作网络，筛选出核心靶点，利用R语言进行GO功能和KEGG通路富集分析,并通过Cytoscape软件构建靶点-通路网络。结果表明，筛选得到145个化合物及相应靶点1618个，关键成分包括木犀草素、山柰酚、川皮苷、柚皮素、黄芩素、金合欢素等,关键靶点包括丝裂原活化蛋白激酶1/3/8/14、半胱氨酸天冬氨酸蛋白酶3/8、白介素6/1β、白蛋白，细胞凋亡调节蛋白、人前列腺素内过氧化物合酶2、原癌基因、RELA原癌基因等。GO功能富集分析显示生物学过程1421条，分子功能63条，细胞组成36条；KEGG通路富集分析显示41条通路,主要涉及PI3K-Akt信号通路、细胞凋亡、内分泌阻力、MAPK 信号通路、Toll样受体信号通路、破骨细胞分化等。研究认为黄芪六君子汤可能通过抗病毒、抗炎、免疫调节等作用机制对新冠肺炎发挥治疗作用。

关键词: 黄芪六君子汤, 新冠肺炎, 网络药理学, 抗病毒, 抗炎

Abstract: We aimed to investigate the mechanism of Huangqi Liujunzi decoction in the treatment of COVID-19 based on Network Pharmacology.The chemical components and targets of Huangqi Liujunzi decoction were collected from the databases of TCMSP, Pubchem, and Swiss Target Prediction and standardized using the Uniprot database.COVID-19 related genes were obtained by the GeneCards database,and we further mapped the common genes of disease and drugs.The protein-protein interaction data were downloaded from the STRING database, and the components-key targets visual network graph and protein interaction network were constructed using Cytoscape software to screen out the core targets.The GO function and KEGG pathway enrichment were analyzed by R language algorithm, and the target-pathway network was constructed using Cytoscape software.The results showed that 145 compounds and 1618 corresponding targets were screened. The key active components included luteolin,kaempferol,nobiletin,naringenin,baicalein, and acacetin.The key targets included MAPK1/3/8/14,CASP3/8,IL6/1β,ALB,apoptosis regulatory protein,PTGS2,protooncogene, and protooncogene of REL.GO function enrichment analysis included 1421 biological processes, 63 molecular functions, and 36 cell components;KEGG pathway enrichment analysis revealed 41 pathways, including PI3K-Akt signaling pathway, apoptosis, endocrine resistance,MAPK signaling pathway,Toll-like receptor signaling pathway,and osteoclast differentiation.Huangqi Liujunzi Decoction has a therapeutic effect on COVID-19 through antiviral, anti-inflammatory, and immune regulation mechanisms.

Key words: Huangqi Liujunzi decoction, COVID-19, network pharmacology, antiviral, anti-inflammatory

中图分类号:

R285

汪宗清, 聂红科, 李青璇, 王兴强, 汤小虎. 基于网络药理学探讨黄芪六君子汤治疗新冠肺炎恢复期的作用机制[J]. 山东科学, 2020, 33(5): 14-26.

WANG Zong-qing, NIE Hong-ke, LI Qing-xuan, WANG Xing-qiang, TANG Xiao-hu. Mechanism of Huangqi Liujunzi decoction in treating the recovery stage of COVID-19 based on network pharmacology[J]. Shandong Science, 2020, 33(5): 14-26.

参考文献 34

1	北京中医药学会肺系病专业委员会.新型冠状病毒肺炎恢复期中医药综合干预方案专家指导意见(草案)[J].北京中医药，2020，39（2）:102-104. doi: 10.16025/j.1674-1307.2020.02.002
2	国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案（试行第七版）的通知[EB/OL].(2020-03-03)[2020-03-05]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtm.
3	国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒感染的肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-23)[2020-04-21].http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2ffcbeel fa.shtml.
4	刘仕廉. 医学集成[M]. 北京: 中国中医药出版社, 2015.
5	塔娜, 张伟. 加味六君子汤治疗小儿过敏性咳嗽缓解期(肺脾气虚型)的临床观察[J]. 中医药信息, 2012, 29(2): 70-71. doi: 10.19656/j.cnki.1002-2406.2012.02.029
6	杨靖罡, 张庆天. 六君子汤加减方治疗老年肺部感染60例[J]. 医药导报, 2010, 29(4): 492-493. doi: 10.3870/yydb.2010.04.031
7	林水玉. 六君子汤治疗慢性阻塞性肺疾病稳定期肺脾气虚型患者的临床研究[D]. 福州: 福建中医药大学, 2013.
8	郝悦, 焦安妮, 于敏, 等. 30种黄酮抑制黄嘌呤氧化酶活性的筛选[J]. 中成药, 2019, 41(1): 55-59. doi: 10. 3969 /j．issn．1001-1528. 2019. 01. 012
9	YU W Y, LI L, WU F, et al. Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4/NF-κB/MLCK pathway[J]. Journal of Ethnopharmacology, 2020, 253: 112641. doi: 10.1016/j.jep.2020.112641
10	邓东沅, 顾立刚, 刘晓婷, 等. 木犀草素体外对H1N1感染A549诱导凋亡的干预作用及机制[J]. 中华中医药杂志, 2017, 32(4): 1524-1527.
11	任开明, 周兆丽, 石文君. 木犀草素对人非小细胞肺癌A549细胞增殖、凋亡、侵袭及迁移能力的影响[J]. 解剖科学进展, 2019, 25(4): 361-363. doi: 10.16695/j.cnki.1006-2947.2019.04.004
12	张雅雯, 邵东燕, 师俊玲, 等. 山奈酚生物功能研究进展[J]. 生命科学, 2017, 29(4): 400-405. doi: 10.13376/j.cbls/2017053
13	HUANG H, LI L F, SHI W M, et al. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro[J]. Evidence-based Complementary and Alternative Medicine, 2016, 2016: 2918796. doi: 10.1155/2016/2918796
14	PATEL K, SINGH G K, PATEL D K. A review on pharmacological and analytical aspects of naringenin[J]. Chinese Journal of Integrative Medicine, 2018, 24(7): 551-560. doi: 10.1007/s11655-014-1960-x
15	马纳, 李亚静, 范吉平. 金合欢素药理研究进展[J]. 中国现代应用药学, 2018, 35(10): 1591-1595. doi: 10.13748/j.cnki.issn1007-7693.2018.10.035
16	ZHI H J, JIN X, ZHU H Y, et al. Exploring the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza a virus induced acute lung injury[J]. Journal of Pharmaceutical and Biomedical Analysis, 2020, 177: 112876. doi: 10.1016/j.jpba.2019.112876
17	WAN Y S, SHANG J, GRAHAM R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus[J].Journal of Virology,2020:31996437. doi: 10.11281 JVI.00127-20
18	刘静,范梦月,孙凯滨,等.基于分子对接柴胡桂枝干姜汤干预初期寒湿郁肺型新型冠状病毒肺炎的活性成分及功效作用机制探讨[J].中草药,2020,51(7):1704-1712. doi: 10.7501/j.issn.0253-2670.2020.07.004
19	姚卫峰,翟园园,林丽丽,等.融合“成分-靶点-共有通路”网络和分子对接技术的清肺口服液抗新型冠状病毒肺炎的活性成分初探[J].南京中医药大学学报,2020,32(2):174-178. doi: 10.14148/j.issn.1672-0482.2020.0174
20	宗阳,丁美林,贾可可,等.基于网络药理学和分子对接法探寻达原饮治疗新型冠状病毒(2019-nCoV)肺炎活性化合物的研究[J].中草药,2020,51(4):836-844. doi: 10.7501/j.issn.0253-2670.2020.04.002
21	邓燕君, 刘博文, 贺桢翔, 等. 基于网络药理学和分子对接法探索藿香正气口服液预防新型冠状病毒肺炎(COVID-19)活性化合物研究[J].中草药, 2020, 51(5): 1113-1122. doi: 10.7501/j.issn.0253-2670.2020.05.004
22	姚运秀, 贺桢翔, 刘晓凤, 等. 基于网络药理学和分子对接技术的抗病毒颗粒治疗新型冠状病毒肺炎(COVID-19)的潜在物质基础研究[J]. 中草药, 2020, 51(6): 1386-1396. doi: 10.7501/j.issn.0253-2670.2020.06.003
23	GUO Y J,PAN W W,LIU S B,et al.ERK/MAPK signalling pathway and tumorigenesis[J].Experimental and Therapeutic Medicine,2020,19(3):1997-2007. doi: 10.38921etm.2020.8454
24	STENNICKE H R, SALVESEN G S. Caspases - controlling intracellular signals by protease zymogen activation[J]. Biochimica et Biophysica Acta, 2000, 1477(1): 299-306. doi: 10.1016/S0167-4838(99)00281-2
25	CHEN C, LIU T S, ZHAO S C, et al. XIAP impairs mitochondrial function during apoptosis by regulating the Bcl-2 family in renal cell carcinoma[J]. Experimental and Therapeutic Medicine, 2018, 15(5): 4587-4593. doi: 10.3892/etm.2018.5974
26	李艺敏, 陈健, 何剑全, 等. 巴戟天含药血清对成骨-破骨细胞共育体系原癌基因、核心结合因子1mRNA表达的影响[J]. 中国老年学杂志, 2015, 35(9): 2328-2331. doi: 10. 3969 /j. issn. 1005-9202. 2015. 09. 010.
27	韩莹, 蔡庆宇, 张岩. 泻肺定喘汤对中性粒细胞型哮喘大鼠KLF-2/RelA比例平衡及中性粒细胞凋亡的影响[J]. 中国中医急症, 2019, 28(4): 607-610, 614. DOI：10.3969/j.issn.1004-745X.2019.04.012.
28	ZHOU B X, YANG Z F, FENG Q T, et al. Aurantiamide acetate from Baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza a virus-infected cells[J]. Journal of Ethnopharmacology, 2017, 199: 60-67. doi: 10.1016/j.jep.2017.01.038
29	LIAO X Z, GAO Y, SUN L L, et al. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway[J]. Phytotherapy Research, 2020, 34(5): 1142-1153. doi: 10.1002/ptr.6584
30	SREEHARSHA N. Embelin impact on paraquat-induced lung injury through suppressing oxidative stress, inflammatory cascade, and MAPK/NF-κB signaling pathway[J].Journal of Biochemical and Molecular Toxicology,2020,34(4):e22456. doi: 10.10021 jbt.22456
31	HU T J, SHEN H B, HUANG H B, et al. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling[J]. Anti-Cancer Drugs, 2020, 31(4): 377-384. doi: 10.1097/CAD.0000000000000885
32	TAN Z C, SHI Y Y, YAN Y, et al. Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats[J]. Renal Failure, 2015, 37(4): 727-733. doi: 10.3109/0886022X.2015.1012983
33	TOTURA A L, WHITMORE A, AGNIHOTHRAM S, et al. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection［J］.American Society for Microbiology,2015,6(3):e00638-15. doi: 10.1128/mBio.00638-15
34	林巧卫, 张思, 陆维祺. NOD样受体介导的信号转导通路及其与肿瘤关系的研究进展[J]. 中国癌症杂志, 2019, 29(3): 223-228. doi: 10.19401/j.cnki.1007-3639.2019.03.011

[1]	刘可春, 王勇澄, 臧晓涵, 夏青, 张云, 张姗姗, 孙晨. 网络药理学和斑马鱼模型在中药药效物质及作用机制研究中的应用进展[J]. 山东科学, 2024, 37(2): 29-35.
[2]	付朝举, 成果, 林登梅, 李军, 张楠楠. 阔叶十大功劳抗炎作用机制的实验研究及网络药理学分析[J]. 山东科学, 2024, 37(1): 24-31.
[3]	陈春, 祁大庆, 潘靖文. 基质细胞评分的胃癌临床意义及胃复春胶囊干预机制[J]. 山东科学, 2023, 36(6): 38-47.
[4]	慕娜娜, 廖彬彬, 李镇, 李吉品, 李伊花, 王莹, 陈旭冰. 基于网络药理学和分子对接技术探究地胆草治疗溃疡性结肠炎的作用机制[J]. 山东科学, 2023, 36(6): 48-55.
[5]	王一帆, 张喆, 田财军. 基于网络药理学和分子对接探讨三黄泻心汤治疗阿尔茨海默病的机制[J]. 山东科学, 2023, 36(5): 19-26.
[6]	付梦雅, 敖慧豪, 卜超, 朋汤义, 吴德玲, 韩燕全, 洪燕. 基于指纹图谱和网络药理学的干姜质量标志物预测分析[J]. 山东科学, 2023, 36(4): 35-41.
[7]	尹志鹏, 高云云, 刘文文, 郭蓬勃, 赵英会. 基于网络药理学和分子对接探讨香砂六君子汤治疗幽门螺杆菌相关性胃炎的作用机制[J]. 山东科学, 2023, 36(4): 52-60.
[8]	孙铁锋, 董丽敏, 焦子麒, 王平. 基于数据挖掘及网络药理学探讨中医药抗呼吸道合胞病毒的用药规律及作用机制[J]. 山东科学, 2023, 36(3): 1-9.
[9]	朱洁, 王征, 梁艳妮. 基于网络药理学探究小青龙汤治疗新型冠状病毒肺炎的作用机制[J]. 山东科学, 2023, 36(3): 10-17.
[10]	董朋峻, 蔡彬. 基于网络药理学与代谢组学探讨枳实-厚朴药对治疗慢传输型便秘的作用机制[J]. 山东科学, 2023, 36(3): 18-26.
[11]	赵鑫, 黄碧云, 吴丹, 张梅. 基于网络药理学和分子对接探讨桂芍镇痫片治疗颞叶癫痫的作用机制[J]. 山东科学, 2023, 36(3): 27-37.
[12]	王一帆, 张艳艳, 田财军. 基于网络药理学探讨尪痹方治疗类风湿性关节炎的机制[J]. 山东科学, 2023, 36(3): 38-45.
[13]	刘文文, 高云云, 尹志鹏, 吕刚, 王玉, 赵英会. 基于网络药理学和分子对接探讨黄连温胆汤治疗幽门螺杆菌相关性胃炎的作用机制[J]. 山东科学, 2023, 36(2): 23-32.
[14]	刘纹纹, 李长庚, 孔娜, 刘双, 董红敬. 基于网络药理学和分子对接研究十味益脾颗粒的作用机制[J]. 山东科学, 2023, 36(2): 33-40.
[15]	申凤霞, 范建伟, 李倩, 马云, 冯群, 关永霞. 基于网络药理学及分子对接探究茵栀黄颗粒治疗肝纤维化的作用机制[J]. 山东科学, 2023, 36(1): 23-33.